Armata Pharmaceuticals (ARMP) Total Debt Growth (1y) (2019 - 2026)
Armata Pharmaceuticals (ARMP) Total Debt Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.10% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 12.42% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -57.72% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 3.78% |
| 10 | Armata Pharmaceuticals | 182.82 Mn | 158.82 Mn | - | 515.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 515.72% |
| Mar 31, 2026 | 217.67% |
| Dec 31, 2025 | 357.26% |
| Sep 30, 2025 | 53.13% |
| Jun 30, 2025 | -30.70% |
| Mar 31, 2025 | -74.12% |
| Dec 31, 2024 | -4.79% |
| Sep 30, 2024 | 85.65% |
| Dec 31, 2020 | 100.00% |
| Sep 30, 2020 | 100.11% |
| Jun 30, 2020 | 110.27% |
| Dec 31, 2019 | 0.00% |